Detalhe da pesquisa
1.
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
Clin Infect Dis
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297916
2.
Development of a Broth Microdilution Method for Exebacase Susceptibility Testing.
Antimicrob Agents Chemother
; 65(7): e0258720, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903102
3.
Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity.
J Clin Microbiol
; 59(7): e0311720, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910968
4.
Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
J Antimicrob Chemother
; 72(10): 2796-2803, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091195
5.
Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing".
Antimicrob Agents Chemother
; 65(10): e0165821, 2021 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34533411
6.
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Antimicrob Agents Chemother
; 60(1): 343-7, 2016 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503659
7.
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program.
Antimicrob Agents Chemother
; 59(12): 7873-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26416860
8.
Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
J Antimicrob Chemother
; 70(9): 2488-98, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26045529
9.
The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics.
Microbiol Spectr
; : e0526122, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862002
10.
Rapid bacteriolysis of Staphylococcus aureus by lysin exebacase.
Microbiol Spectr
; : e0190623, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37561151
11.
New Antimicrobial Agentsââ ââbut No Susceptibility Tests!
Clin Infect Dis
; 63(11): 1530-1531, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27581762
12.
Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation.
Microb Drug Resist
; 9(1): 17-24, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12705679
13.
Examination of single and multiple mutations involved in resistance to quinolones in Staphylococcus aureus by a combination of PCR and denaturing high-performance liquid chromatography (DHPLC).
J Antimicrob Chemother
; 50(5): 649-55, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12407120